Bariatric surgery: Effects on the metabolic complications of obesity

Current Atherosclerosis Reports

Volumn 14, Issue 2, 2012, Pages 95-100

  Clifton, Peter M ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Dyslipidemia; Gastric band; Gastric bypass; HDL; Hypertension; LAGB; LDL; Mortality; RYGB; Sleep apnea; TG; Type 2 diabetes

Indexed keywords

ADIPONECTIN; CERAMIDE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INCRETIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; BARIATRIC SURGERY; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; GASTRIC BANDING; HEART LEFT VENTRICLE PERFORMANCE; HEART RIGHT VENTRICLE PERFORMANCE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; REMISSION; RISK ASSESSMENT; RISK FACTOR; SLEEP APNEA SYNDROME; STOMACH BYPASS; SURVIVAL RATE; WEIGHT REDUCTION;

BARIATRIC SURGERY; BODY MASS INDEX; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; HUMANS; MALE; METABOLIC SYNDROME X; OBESITY, MORBID; SURVIVAL RATE; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84861235146     PISSN: 15233804     EISSN: 15346242     Source Type: Journal    
DOI: 10.1007/s11883-012-0231-6     Document Type: Article

References (51)

1. Colquitt JL, Picot J, Loveman E, Clegg AJ. Surgery for obesity. Cochrane Database Syst Rev. 2009 Apr;15(2):CD003641. This article states that long-term evidence for the benefit of bariatric surgery is not available but is urgently required.
2. Nguyen NT, Masoomi H, Magno CP, et al. Trends in use of bariatric surgery, 2003-2008. J Am Coll Surg. 2011 May 28. Epub.
3. Snyder B, Wilson T, Mehta S, et al. Past, present, and future: critical analysis of use of gastric bands in obese patients. Diabetes Metab Syndr Obes. 2010;3:55-65.
4. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724-37. (Pubitemid 39346675)
5. Cunneen SA. Review of meta-analytic comparisons of bariatric surgery with a focus on laparoscopic adjustable LAGB. Surg Obes Relat Dis. 2008;4:S47-55. (Pubitemid 351689962)
6. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and metaanalysis. Am J Med. 2009;122:248-256.e5.
7. Sjöström L, Lindroos AK, Peltonen M, et al. Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-93.
8. Nocca D, Guillaume F, Noel P, et al. Impact of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on HbA1c blood level and pharmacological treatment of type 2 diabetes mellitus in severe or morbidly obese patients. Results of a multicenter prospective study at 1 year. Obes Surg. 2011;21:738-43. The new and simpler sleeve gastrectomy is just as effective at improving diabetes as RYGB.
9. Chouillard EK, Karaa A, Elkhoury M, Greco VJ; Intercontinental Society of Natural Orifice, Endoscopic, and Laparoscopic Surgery (i-NOELS). Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for morbid obesity: case-control study. Surg Obes Relat Dis. 2011 Mar 8. [Epub ahead of print].
10. Abbatini F, Rizzello M, Casella G, et al. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc. 2010;24:1005-10. The early benefit seen with RYGB postulated to be due to exclusion of the foregut and rapid entry of nutrients into the hindgut is also seen with sleeve gastrectomy, which has no foregut exclusion.
11. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable LAGB and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299:316-23. (Pubitemid 351159368)
12. Dixon JB, O'Brien PE. Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic LAGB. Diabetes Care. 2002;25:358-63. (Pubitemid 41079636)
13. Kadera BE, Lum K, Grant J, et al. Remission of type 2 diabetes after Roux-en-Y RYGB is associated with greater weight loss. Surg Obes Relat Dis. 2009;5:305-9.
14. Hall TC, Pellen MG, Sedman PC, Jain PK. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y RYGB surgery for obesity. Obes Surg. 2010;20:1245-50. Poor control of diabetes (HbA1c > 10% and diabetes duration > 10 years) predicts lower remission rates.
15. Dixon JB, Dixon AF, O'Brien PE. Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Homeostatic model assessment. Diabet Med. 2003;20:127-34. (Pubitemid 36269654)
16. Geloneze B, Geloneze SR, Fiori C, et al. Surgery for nonobese type 2 diabetic patients: an interventional study with duodenaljejunal exclusion. Obes Surg. 2009;19:1077-83. Foregut exclusion improves insulin-treated diabetes without inducing weight loss.
17. DiGiorgi M, Rosen DJ, Choi JJ, et al. Re-emergence of diabetes after RYGB in patients with mid- to long-term follow-up. Surg Obes Relat Dis. 2010;6:249-53. Recurrence of type 2 diabetes mellitus can be seen in 20% of patients following gastric bypass.
18. Laferrère B, Teixeira J, McGinty J, et al. Effect of weight loss by RYGB surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab. 2008;3:2479-85. (Pubitemid 352008510)
19. Laferrère B, Swerdlow N, Bawa B, et al. Rise of oxyntomodulin in response to oral glucose after RYGB surgery in patients with type 2 diabetes. J Clin Endocrinol Metab. 2010;95:4072-6.
20. Beckman LM, Beckman TR, Earthman CP. Changes in gastrointestinal hormones and leptin after Roux-en-Y RYGB procedure: a review. J Am Diet Assoc. 2010;110:571-84. This is a useful review on hormonal changes after gastric bypass.
21. Shak JR, Roper J, Perez-Perez GI, et al. The effect of laparoscopic LAGB surgery on plasma levels of appetite-control, insulinotropic, and digestive hormones. Obes Surg. 2008;18:1089-96.
22. Cui Y, Elahi D, Andersen DK. Advances in the etiology and management of hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass. J Gastrointest Surg. 2011 Jun 14. [Epub ahead of print]. Hypoglycemia is not an uncommon complication of RYGB.
23. Salinari S, Bertuzzi A, Asnaghi S, et al. First-phase insulin secretion restoration and differential response to glucose load depending on the route of administration in type 2 diabetic subjects after bariatric surgery. Diabetes Care. 2009;32:375-80.
24. Lima MM, Pareja JC, Alegre SM, et al. Acute effect of roux-en-y RYGB on whole-body insulin sensitivity: a study with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95:3871-5.
25. Navaneethan SD, Kelly KR, Sabbagh F, et al. Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery. Obes Surg. 2010;20:308-15.
26. Camastra S, Gastaldelli A, Mari A, et al. Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. Diabetologia. 2011 May 26. [Epub ahead of print]. A comprehensive look at glucose metabolism after RYGB.
27. Appachi S, Kelly KR, Schauer PR, et al. Reduced cardiovascular risk following bariatric surgeries is related to a partial recovery from "adiposopathy". Obes Surg. 2011 May 28. [Epub ahead of print].
28. Sjöström CD, Peltonen M, Sjöström L. Blood pressure and pulse pressure during long-term weight loss in the obese: the Swedish Obese Subjects (SOS) Intervention Study. Obes Res. 2001;9:188-95. (Pubitemid 33600279)
29. Sugerman HJ, Wolfe LG, Sica DA, Clore JN. Diabetes and hypertension in severe obesity and effects of gastricbypass-induced weight loss. Ann Surg. 2003;237:751-6.
30. Frigg A, Peterli R, Peters T, et al. Reduction in comorbidities 4 years after LAGB. Obes Surg. 2004;14:216-23.
31. De Ciuceis C, Porteri E, Rizzoni D, et al. Effects of weight loss on structural and functional alterations of subcutaneous small arteries in obese patients. Hypertension. 2011;58:29-36. Small cutaneous arteries in obese patients are abnormal well before hypertension occurs but the changes are reversible.
32. Gasa M, Salord N, Fortuna AM, et al. Obstructive sleep apnoea and metabolic impairment in severe obesity. Eur Respir J. 2011 May 26. [Epub ahead of print].
33. Higa K, Ho T, Tercero F, et al. Laparoscopic Roux-en-Y gastric bypass: 10-year follow-up. Surg Obes Relat Dis. 2010 Nov 26. [Epub ahead of print].
34. Hsu CY, Iribarren C, McCulloch CE, et al. Risk factors for endstage renal disease: 25-year follow-up. Arch Intern Med. 2009;169:342-50.
35. Afshinnia F, Wilt TJ, Duval S, et al. Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. Nephrol Dial Transplant. 2010;25:1173-83.
36. Navaneethan SD, Yehnert H, Moustarah F, et al. Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009;4:1565-74. This is an excellent review on the effect of weight loss on renal function.
37. Zlabek JA, Grimm MS, Larson CJ, et al. The effect of laparoscopic gastric bypass surgery on dyslipidemia in severely obese patients. Surg Obes Relat Dis. 2005;1:537-42.
38. Nguyen NT, Varela E, Sabio A, et al. Resolution of hyperlipidemia after laparoscopic Roux-en-Y gastric bypass. J Am Coll Surg. 2006;203:24-9.
39. Kim S, Richards WO. Long-term follow-up of the metabolic profiles in obese patients with type 2 diabetes mellitus after Roux-en-Y RYGB. Ann Surg. 2010 Jun;251(6):1049. There is good long-term control of triglycerides and HDL after weight loss.
40. Haus JM, Kashyap SR, Kasumov T, et al. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes. 2009;58:337-43. Ceramides appear to play a role in insulin resistance.
41. Huang H, Kasumov T, Gatmaitan P, et al. gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients. Obesity (Silver Spring). 2011 May 5. [Epub ahead of print]. This article provides more data on the role of ceramides in insulin resistance.
42. Benaiges D, Goday A, Ramon JM, et al.; Obemar Group. Laparoscopic sleeve gastrectomy and laparoscopic gastric bypass are equally effective for reduction of cardiovascular risk in severely obese patients at 1 year of follow-up. Surg Obes Relat Dis. 2011 Mar 17. [Epub ahead of print].
43. Habib P, Scrocco JD, Terek M, et al. Effects of bariatric surgery on inflammatory, functional and structural markers of coronary atherosclerosis. Am J Cardiol. 2009;104:1251-5.
44. Sturm W, Tschoner A, Engl J, et al. Effect of bariatric surgery on both functional and structural measures of premature atherosclerosis. Eur Heart J. 2009;30:2038-43.
45. Garza CA, Pellikka PA, Somers VK, et al. Structural and functional changes in left and right ventricles after major weight loss following bariatric surgery for morbid obesity. Am J Cardiol. 2010;105:550-6.
46. Ikonomidis I, Mazarakis A, Papadopoulos C, et al. Weight loss after bariatric surgery improves aortic elastic properties and left ventricular function in individuals with morbid obesity: a 3-year follow-up study. J Hypertens. 2007;25:439-47. (Pubitemid 46071943)
47. Rider OJ, Francis JM, Ali MK. Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity. J Am Coll Cardiol. 2009;54:718-26.
48. Sjöström L, Narbro K, Sjöström CD, Swedish Obese Subjects Study, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741-52. (Pubitemid 47295641)
49. Flum DR,Dellinger EP. Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg. 2004;199:543-51. (Pubitemid 39420204)
50. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753-61. (Pubitemid 47295642)
51. Maciejewski ML, Livingston EH, Smith VA, et al. Survival among high-risk patients after bariatric surgery. JAMA. 2011;305:2419-26. Survival was not improved with bariatric surgery in patients with a high mortality risk, thus providing an argument for earlier intervention.